Latest Breaking News On - Months of development alpha emitting therapies - Page 1 : comparemela.com

/PRNewswire/ Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company"), a leader in the development of targeted radiotherapies for.

Hans vitzthumMary chenHelen kotanidesPreclinical developmentLifesci advisorsExchange commissionMonths of development alpha emitting therapiesAstellas pharma incActinium pharmaceuticals incTranslational researchClinical developmentMemorial sloan kettering cancer centerActinium pharmaceuticalsTargeted radiopharmaceuticals summitTargeted radiopharmaceuticalsAlpha emitting therapies